No Data
Landfar Bio-medicine: 2024 Interim Performance Forecast
Even After Rising 17% This Past Week, Landfar Bio-medicine (SZSE:000504) Shareholders Are Still Down 59% Over the Past Three Years
[BT Financial Report Analysis] Landfar Bio-medicine Q1 2024 Report: Comprehensive Analysis of Assets, Liabilities, Profits and Cash Flow.
Landfar Bio-medicine (Stock Code: 000504) is an enterprise that specializes in the biomedical field, particularly with significant advantages in the cell industry. The company is committed to researching and applying advanced medical technologies such as stem cells, immune cells, and gene therapy, and has performed well in the commercialization of cell therapy products. With the deepening of domestic cell therapy research and the expansion of the market scale, Landfar Bio-medicine is expected to continue its leading position in this field. In addition, the company pays attention to the development of energy-saving and environmentally friendly industries, which is in line with the national green development strategy and promotes sustainable development. In the first quarter of 2024, Landfar Bio-medicine's capital...
Nanhua Biology (000504.SZ): Currently, beauty products such as essences, masks, and creams are still in their infancy
Gelonghui, May 24 | Nanhua Biology (000504.SZ) said on the investor interactive platform that the company currently has beauty products such as essences, masks, creams, etc. Currently, the main products on sale are EE18 Sturgeon Caviar Polypeptide Anti-Wrinkle Essence, EE18 Hydrolyzed Collagen Firming Kit, and EE18 Hydrolyzed Collagen Firming Mask. Currently, the beauty business is still in its infancy.
Landfar Bio-medicine Co., Ltd's (SZSE:000504) 30% Share Price Surge Not Quite Adding Up
Nanhua Biology (000504.SZ): The company does not yet have synthetic biotechnology
Gelonghui, May 8, 丨 Nanhua Biology (000504.SZ) said on the investor interactive platform that the company does not yet have synthetic biotechnology-related technology. The company's biomedical business is mainly cell storage, and also studies applications and services related to stem cells and immune cells. Among them, cell storage includes stem cell storage and immune cell storage. Applied research mainly includes stem cells to treat lung damage, mesenchymal stem cells treat gestational diabetes, basic and clinical research on stem cells to treat kidney disease, research on the molecular mechanisms of umbilical cord mesenchymal stem cell exosomes in skin damage repair, and umbilical cord mesenchymal stem cells
There's Reason For Concern Over Landfar Bio-medicine Co., Ltd's (SZSE:000504) Massive 45% Price JumpNo Data
